Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Shares Outstanding (Weighted Average) (2020 - 2025)

Maravai Lifesciences Holdings has reported Shares Outstanding (Weighted Average) over the past 6 years, most recently at $144.4 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Weighted Average) at $144.4 million for Q4 2025, up 4.68% from a year ago — trailing twelve months through Dec 2025 was $144.4 million (up 4.68% YoY), and the annual figure for FY2025 was $144.4 million, up 4.68%.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $144.4 million at Maravai Lifesciences Holdings, roughly flat from $144.7 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for MRVI hit a ceiling of $144.7 million in Q3 2025 and a floor of $96.6 million in Q1 2021.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $131.9 million (2023), compared with a mean of $130.9 million.
  • Peak annual rise in Shares Outstanding (Weighted Average) hit 1008.98% in 2021, while the deepest fall reached 61.94% in 2021.
  • Maravai Lifesciences Holdings' Shares Outstanding (Weighted Average) stood at $114.8 million in 2021, then grew by 14.6% to $131.5 million in 2022, then rose by 0.28% to $131.9 million in 2023, then increased by 4.54% to $137.9 million in 2024, then grew by 4.68% to $144.4 million in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $144.4 million (Q4 2025), $144.7 million (Q3 2025), and $143.8 million (Q2 2025) per Business Quant data.